Trials / Completed
CompletedNCT00820664
A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women
A Randomized Clinical Trial to Evaluate the Effects of Estrogen on Uterine Endometrium in Healthy Postmenopausal Women
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the effect of two different dose levels of estrogen or placebo in healthy postmenopausal women by measuring the changes in hormone levels and examining the changes in the uterine lining (endometrium).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Comparator: Estrace 0.5 mg | 0.5 mg tablet taken once daily for 28 days |
| DRUG | Comparator: Estrace 2 mg | 2 mg tablets taken once daily for 28 days. |
| DRUG | Comparator: Placebo | Placebo 0 mg capsule taken once daily for 28 days |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2009-01-12
- Last updated
- 2016-01-22
- Results posted
- 2010-05-07
Source: ClinicalTrials.gov record NCT00820664. Inclusion in this directory is not an endorsement.